<DOC>
	<DOC>NCT00909142</DOC>
	<brief_summary>The effect of Bonefos on consumption of analgesics (drugs used for pain treatment) in patients with proven bone metastases.</brief_summary>
	<brief_title>Bonefos and the Consumption of Analgesics</brief_title>
	<detailed_description />
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Clodronic Acid</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Breast cancer or prostate cancer or multiple myeloma. Bone metastasis. Ability to use analgesics and clodronate 1600 mg/day. Hypersensitivity to bisphosphonates. Clodronate in previous therapy. Concomitant use of other bisphosphonates. Serious renal insufficiency.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>Multiple myeloma</keyword>
</DOC>